AJP - Endo Journal of Neurophysiology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Am J Physiol Endocrinol Metab 290: E989-E997, 2006. First published December 27, 2005; doi:10.1152/ajpendo.00459.2005
0193-1849/06 $8.00
This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
290/5/E989    most recent
00459.2005v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (5)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Beha, A.
Right arrow Articles by Herling, A. W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Beha, A.
Right arrow Articles by Herling, A. W.

Muscle type-specific fatty acid metabolism in insulin resistance: an integrated in vivo study in Zucker diabetic fatty rats

Anja Beha,1 Hans-Paul Juretschke,1 Johanna Kuhlmann,1 Claudia Neumann-Haefelin,1 Ulrich Belz,1 Martin Gerl,1 Werner Kramer,1 Michael Roden,2,3 and Andreas W. Herling1

1Sanofi-Aventis Deutschland, Frankfurt am Main, Germany; 2Medical Department, Hanusch Hospital; and 3Division of Endocrinology and Metabolism, Department of Internal Medicine III, Medical University of Vienna, Vienna, Austria

Submitted 21 September 2005 ; accepted in final form 18 December 2005


    ABSTRACT
 TOP
 ABSTRACT
 RESEARCH DESIGN AND METHODS
 RESULTS
 DISCUSSION
 REFERENCES
 
Intramyocellular lipid content (IMCL) serves as a good biomarker of skeletal muscle insulin resistance (IR). However, intracellular fatty acid metabolites [malonyl-CoA, long-chain acyl-CoA (LCACoA)] rather than IMCL are considered to be responsible for IR. This study aimed to investigate dynamics of IMCL and fatty acid metabolites during fed-to-starved-to-refed transition in lean and obese (IR) Zucker diabetic fatty rats in the following different muscle types: soleus (oxidative), extensor digitorum longus (EDL, intermediary), and white tibialis anterior (wTA, glycolytic). In the fed state, IMCL was significantly elevated in obese compared with lean rats in all three muscle types (soleus: 304%, EDL: 333%, wTA: 394%) in the presence of elevated serum triglycerides but similar levels of free fatty acids (FFA), malonyl-CoA, and total LCACoAs. During starvation, IMCL in soleus remained relatively constant, whereas in both rat groups IMCL increased significantly in wTA and EDL after comparable dynamics of starvation-induced FFA availability. The decreases of malonyl-CoA in wTA and EDL during starvation were more pronounced in lean than in obese rats, although there were no changes in soleus muscles for both groups. The concomitant increase in IMCL with the fall of malonyl-CoA support the concept that, as a reaction to starvation-induced FFA availability, muscle will activate lipid oxidation more the lower its oxidative capacity and then store the rest as IMCL.

insulin resistance; intramyocellular lipids; fatty acids; muscle fiber type; Zucker diabetic fatty rat; lipid metabolism


THE CLOSE LINK BETWEEN CARBOHYDRATE and lipid metabolism is unequivocally demonstrated by the findings that 1) obesity is linked to insulin resistance (IR; see Refs. 5, 45, 53), 2) fat feeding induces IR (40), and 3) body weight reduction reduces IR (15, 17). Recent studies in humans and animals showed a strong relationship between IR and increased lipid content in nonadipose tissue like muscle (2, 4, 16, 20, 26, 41, 57) and liver (1, 34, 49). Skeletal muscle accounts for up to 90% of insulin-stimulated glucose disposal (54). In untrained individuals, IR correlates well with intramyocellular lipid content (IMCL) (26, 29, 32, 35, 41), which can be measured noninvasively by 1H magnetic resonance spectroscopy (MRS) in humans (6, 52, 56) and rats (21, 27).

The molecular basis for the interaction of glucose and fatty acid metabolism is still not completely elucidated. In addition to Randle et al.'s (42) glucose-fatty acid cycle, whose entire validity has been repeatedly questioned (46, 47, 53), other mechanisms were proposed to explain how fatty acids impair glucose metabolism. Muscle triglycerides themselves do not seem to interfere directly with insulin action but reflect rather some other lipid-dependent changes resulting in IR (9, 35). Good candidates are presently metabolites derived from intramyocellular fatty acids, like long-chain fatty acyl-CoAs (LCACoAs; see Refs. 9, 18, 61), which are thought to activate directly or indirectly via diacylglycerol (19, 38)-specific protein kinase C isoforms (19, 61), ultimately resulting in the inhibition of insulin signaling molecules by serine phosphorylation and impairment of glucose uptake (53).

Whether skeletal IMCL levels and IR are causally connected remains unclear. The failure to clarify this relationship is probably also related with the often used generic concept "skeletal muscle," which fails to account for the large functional and metabolic variability of muscle tissue. The rat has muscles with highly specific fiber types and thus offers the chance to study their specific response.

Fatty acid metabolism in skeletal muscle is far from being homogenous when different fiber types are compared with respect to biochemical and physiological properties. Skeletal muscle comprises the following four different fiber types: one slow-twitch fiber type (type I, oxidative) and two fast-twitch fiber types (type IIA, oxidative/glycolytic and type IIB, nonoxidative/glycolytic), as well as an additional fiber type named IID/X, which is in between type IIA and IIB fibers (11). During a 5-day fed-starvation-refed study in Wistar rats, the elevation of plasma free fatty acids (FFA) led to muscle type-specific responses in intramyocellular fatty acid metabolism (39); in nonoxidative muscles, IMCL levels increased significantly during starvation, whereas in the oxidative soleus muscle IMCL levels remained constant. Similar muscle type-specific differences in starvation-induced dynamics of IMCL have recently been demonstrated also in humans (58). In our study with Wistar rats (39), in the glycolytic longissimus dorsi muscle, LCACoA levels remained constant during the starvation period. From these findings it was concluded that, during starvation-induced adipocytic lipolysis, oxidative muscle disposes elevated FFA by oxidation, whereas nonoxidative muscles neutralize FFA by reesterification. Both mechanisms might prevent the impairment of insulin signaling by keeping the levels of LCACoAs low.

The present study was performed to characterize dynamics of fatty acid metabolites, in relationship with IR. We chose the adolescent male obese Zucker diabetic fatty (ZDF) rat as the animal model displaying an insulin-resistant prediabetic condition. The muscles white tibialis anterior (wTA, predominantly type IIB fibers), extensor digitorum longus (EDL, mainly type IIB fibers), and soleus (predominantly type I fibers) were selected to cover the spectrum from glycolytic to oxidative fiber type. In these three muscles, IMCL levels and dynamics during fed-to-starved-to-refed transition were investigated and correlated with levels of malonyl-CoA, with individual types and levels of LCACoAs, and with relevant plasma parameters (glucose, insulin, triglycerides, FFA, and ketone bodies) in an integrated effort to identify key differences between insulin-resistant and -sensitive metabolism.


    RESEARCH DESIGN AND METHODS
 TOP
 ABSTRACT
 RESEARCH DESIGN AND METHODS
 RESULTS
 DISCUSSION
 REFERENCES
 
Animals. Male lean (ZDF/Crl-+/?) and obese (ZDF/Crl-fa/fa) ZDF rats were obtained from Charles River (Sulzfeld, Germany) and were studied at the age of 8 wk. Animals were housed in pairs at 20°C and on a 12:12-h light-dark cycle with ad libitum access to water.

Experimental protocol. All experimental procedures were conducted according to the German Animal Protection Law. The study protocol included groups of lean and obese ZDF rats; the study ran for 5 days and consisted of the following study points: normal fed; 24, 48, and 72 h starvation; and refed. At each study point, body weight and metabolic serum parameters were measured.

MRS groups. IMCL values were determined repeatedly in all animals (n = 8 lean and obese) by in vivo 1H-MRS in wTA (glycolytic), EDL (intermediary), and soleus (oxidative).

Satellite groups. In parallel groups (n = 8 lean and obese for each study point), defined tissue samples were collected as follows: wTA, EDL, and soleus muscles of both hindlegs were isolated and immediately frozen in liquid nitrogen. In these samples, malonyl-CoA and total creatine (tCr) levels were determined. LCACoA levels in these three muscles were measured in additional rats at the study points mentioned in Experimental protocol (except the 48-h time point). Furthermore, insulin sensitivity was determined with the euglycemic-hyperinsulinemic glucose clamp in additional rats (n = 6 lean and obese) both after 24 and 72 h of starvation.

MRS. In vivo MRS studies in anaesthetized rats were performed on a 7 Tesla Biospec system (Bruker BioSpin, Ettlingen, Germany) as described previously (27). Briefly, IMCL was observed using a single voxel spectroscopy sequence. IMCL was determined as IMCL-to-tCr-ratio in the three muscles. The validity of this approach was checked by biochemical determination of tCr in muscle tissue samples. There was a difference of ~35% in the tCr content of soleus vs. wTA. Therefore, IMCL values were normalized to biochemically determined tCr in wTA.

Euglycemic-hyperinsulinemic glucose clamp study. To investigate insulin sensitivity in lean and obese rats, euglycemic-hyperinsulinemic glucose clamp studies with infusion rates of 9.6 mU·kg–1·min insulin and 1 mg·kg–1·min–1 [U-13C]glucose were performed under pentobarbital sodium anesthesia as described previously (39) after both a 24-h and a 72-h period of starvation.

Monitoring of metabolic serum parameters. Blood samples were taken from the tip of the tail for determination of blood glucose. Samples for monitoring of FFA, ketone bodies, triglycerides, and insulin were obtained by puncture of the sternal venous plexus during short-term isoflurane anesthesia. Blood samples were obtained from all groups (MRS and satellite groups). Representative values are shown from the MRS groups.

Analytical procedures of blood parameters. Standard procedures were used to determine blood glucose, FFA, ketone bodies, and triglycerides (3). Plasma insulin concentrations were assayed by RIA (Linco).

HPLC analysis of malonyl-CoA, tCr, and LCACoAs. HPLC analysis was performed using a Waters Alliance 2690 system (2487 detector; Millennium 2010 chromatographic manager).

Measurements of malonyl-CoA and tCr in muscle were performed in freeze-dried tissue as described previously, whereas analysis of LCACoAs was slightly modified (39).

Tissue was homogenized, and C17:0-CoA was added as an internal standard. LCACoAs were then extracted from the tissue. After centrifugation, the supernatant was applied to a solid-phase extraction column. An aliquot of the resulting eluate was then applied to the HPLC column. The gradient system included three mobile phases, as follows: KH2PO4 (25 mmol/l, pH 4.9), acetonitrile (ACN), and methanol. The starting conditions were 40% KH2PO4, 30% ACN, and 30% methanol. The flow rate was set at 0.4 ml/min. Over 30 min, ACN increased to 50%, whereas KH2PO4 decreased to 20% and methanol remained constant at 30%. The sum of the major species (C16:0, C16:1, C18:0, C18:1, C18:2, and C20:4) was referred to as total LCACoAs, the sum of C16:0, C16:1, C18:0, and C18:1 was referred to as saturated plus monounsaturated (SAT + MUFA), and the sum of C18:2 and C20:4 was referred to as polyunsaturated (PUFA) LCACoAs.

Enzymatic characterization of muscle tissue. To characterize the individual muscles biochemically, the maximal activity of four enzymes involved in energy metabolism was determined in tissue extracts of fed rats: glycogen phosphorylase (GPase, EC 2.4.1.1 [EC] ) as an indicator for glycogen breakdown; hexokinase (HK, EC 2.7.1.1 [EC] ), as such for glucose transport and phosphorylation; glyceraldehyde-3-phosphate dehydrogenase (GAPDH, EC 1.2.1.12 [EC] ) and beta-hydroxyacyl-CoA dehydrogenase (HOAD, EC 1.1.1.35 [EC] ) as markers for glycolysis and mitochondrial fatty acid oxidation. Enzymatic activities were assayed according to standard procedures (3).

Statistical analysis. Data are presented as means ± SE. Statistical differences between lean and obese rats at the different study points were determined using a one-way ANOVA followed by a post hoc analysis with Bonferroni's correction. When testing for differences between the different study points, a two-factor ANOVA (for repeated measures) followed by a post hoc analysis with Bonferroni's correction was used (software package SigmaStat; Jandel, Erkrath, Germany). The differences in the relationship of GAPDH-to-HOAD and GPase-to-HK-ratio between lean and obese animals were tested using a one-way ANCOVA (SPSS; SPSS, Chicago, IL). P < 0.05 was considered to be statistically significant.


    RESULTS
 TOP
 ABSTRACT
 RESEARCH DESIGN AND METHODS
 RESULTS
 DISCUSSION
 REFERENCES
 
Biochemical muscle characterization. The biochemical values allowed clear classification of the "fast-twitch" wTA by a high glycogenolytic and glycolytic together with a low lipid oxidative activity, with the corresponding values for the "slow-twitch" soleus indicating the opposite (Table 1). EDL values were in between. The GAPDH-to-HOAD ratio, reflecting glycolysis relative to lipid oxidation, decreased from glycolytic over intermediate to oxidative muscle. However, in all obese ZDF muscles, maximal HK activity was reduced, which, combined with a tendency toward higher GPase activity, resulted in higher GPase-to-HK-ratios (P < 0.001) for all types. On plotting the GAPDH-to-HOAD against the GPase-to-HK-values for the three muscle types of each strain, we obtained excellent linear correlations (Spearman correlation; lean ZDF: r = 0.903, P < 0.001; obese ZDF: r = 0.895, P < 0.001). These correlation lines were significantly different (ANCOVA, P < 0.001). The lipid oxidative capacity was reduced only in wTA of obese vs. lean animals (P < 0.05).


View this table:
[in this window]
[in a new window]
 
Table 1. Enzymatic characterization of muscle types from fed lean and obese ZDF rats

 
Glucose clamp. After 24 h of starvation, obese rats displayed a significantly lower glucose infusion rate (GIR, P < 0.001) and glucose disposal (Rd, P < 0.001) value during the clamp compared with lean littermates, indicative of their marked IR (Table 2). Prolonged starvation of 72 h in obese rats had no effect on insulin sensitivity during the clamp in terms of GIR and Rd. In lean rats, however, prolonged starvation of 72 h caused a significant increase of basal Rd (= basal endogenous glucose production, EGP). Furthermore, during the clamp, a significantly lower GIR was required to maintain euglycemia than after the 24-h fast. However, there was still a significant difference between both groups with regard to GIR (P < 0.001) and Rd (P < 0.05) after prolonged fasting of 72 h, reflecting the IR condition of the obese animals.


View this table:
[in this window]
[in a new window]
 
Table 2. Mean values of GIR, EGP, Rd, FFA, and insulin during euglycemic hyperinsulinemic glucose clamp studies

 
Body weight and metabolic serum parameters. The changes of body weight and metabolic serum parameters during the study period were similar for the MRS and satellite groups (representatively shown for the MRS groups in Fig. 1). In the fed state, body weight, blood glucose, insulin, and triglyceride levels of the obese rats were increased (P < 0.001) compared with their lean littermates. Ketone bodies and FFA levels were not different between both groups.


Figure 1
View larger version (19K):
[in this window]
[in a new window]
 
Fig. 1. Representative values for body weight (A), blood glucose (B), insulin (C), free fatty acids (FFA; D), ketone bodies (hydroxybutyrate + acetoacetate; E), and triglyceride (F) during fed, 24-, 48-, and 72- h-fasted, and refed conditions in male lean ({circ}) and obese (bullet) Zucker diabetic fatty (ZDF) rats. All values are from one group of animals (magnetic resonance spectroscopy group). Values are means ± SE; n = 8 rats. *P < 0.05 and **P < 0.001 vs. fed condition; {dagger}P < 0.05 and {dagger}{dagger}P < 0.001 vs. lean.

 
During transition from fed to fasted, blood glucose decreased, with the obese group reaching normoglycemia. Insulin and triglyceride levels also decreased during starvation. Both groups exhibited similar plasma FFA levels up to 48 h of starvation. Thereafter, the lean animals had evidently depleted their lipid stores and FFA decreased. In the lean group, ketone values followed FFA development and also decayed at 72 h, reflecting exhaustion of fat stores. In the obese rats, ketone body increase was delayed, indicating an impaired hepatic fatty acid oxidation. These entire results are consistent with metabolism during starvation. Refeeding after 3 days caused an immediate reversal of all parameters (Fig. 1).

Malonyl-CoA. In the fed state, malonyl-CoA levels for every muscle type were similar in both strains (Fig. 2). In the obese, malonyl-CoA levels were significantly elevated in their wTA but reduced in their EDL. In soleus, malonyl-CoA levels did not vary throughout the study in either group. During starvation, the lean group showed larger malonyl-CoA changes than the obese, and the changes increased with rising glycolytic capacity. In the lean rats, malonyl-CoA in wTA and EDL decreased significantly during the first 48 h in the obese only in wTA, reaching a minimum at 24 h, whereas EDL showed no variation.


Figure 2
View larger version (10K):
[in this window]
[in a new window]
 
Fig. 2. Malonyl-CoA contents of white tibialis anterior (wTA; A), extensor digitorum longus (EDL; B), and soleus (SOL; C) muscle during fed, 24-, 48-, and 72-h-fasted, and refed conditions in male lean ({circ}) and obese (bullet) ZDF rats. All values are from separate groups (satellite groups). Values are means ± SE; n = 8. *P < 0.05 and **P < 0.001 vs. fed condition; {dagger}P < 0.05 and {dagger}{dagger}P < 0.001 vs. lean.

 
IMCL. In the fed state, IMCL levels of the obese rats were significantly higher in all muscles than in their lean littermates (Fig. 3). The relative IMCL interstrain differences were most pronounced in wTA (394%) followed by EDL and soleus (333% and 304%, respectively). During starvation, IMCL in wTA and EDL rose significantly in both groups (Fig. 3, A and B), whereas in soleus of lean rats the increase was much lower, and in obese rats IMCL levels remained constant (Fig. 3C). In the lean group, IMCL values for all three muscles declined already at 48 h, again indicating depletion of lipid stores. On refeeding, IMCL levels normalized (Fig. 3).


Figure 3
View larger version (8K):
[in this window]
[in a new window]
 
Fig. 3. Intramyocellular lipid content (IMCL) of wTA (A), EDL (B), and SOL (C) during fed, 24, 48, and 72 h fasted, and refed conditions in male lean ({circ}) and obese (bullet) ZDF rats. Values are means ± SE; n = 8. *P < 0.05 and **P < 0.001 vs. fed condition; {dagger}P < 0.05 and {dagger}{dagger}P < 0.001 vs. lean.

 
LCACoA. Levels of total LCACoA in wTA, EDL, and soleus were similar in fed lean and obese rats (Table 3) and did not correlate with their corresponding IMCL values. The lowest absolute values for total LCACoA levels were in the glycolytic wTA, the highest in the oxidative soleus muscle for both groups. When subgrouping LCACoA species to SAT + MUFA and PUFA, the values for SAT + MUFA in the fed state were significantly higher in obese compared with lean rats in all three muscle types. Furthermore, we observed a significant increase in SAT + MUFA levels in the insulin-resistant obese animals during starvation, whereas SAT + MUFA in lean rats increased transiently in EDL and in soleus muscle, not in wTA, during the first 24 h of starvation but decreased to fed values or even below during prolonged starvation.


View this table:
[in this window]
[in a new window]
 
Table 3. Composition of LCACoA during fed, 24 -h and 72 -h-fasted, and refed conditions in male ZDF rats (lean and obese)

 
During early starvation, when IMCL increased strongly in wTA and EDL but not in soleus, total LCACoA levels changed significantly solely in EDL of both strains. For the SAT + MUFA subgroup, however, a prolonged increase was observed in the obese animals, but not in the lean animals, in all three muscles.

In the lean group, a decrease of total LCACoA levels was observed at 72 h of starvation (Table 3). This is consistent with the incipient drop of FFA, ketone bodies, and IMCL observed in this group already at 48 h of starvation and reflects the depletion of lipid stores.


    DISCUSSION
 TOP
 ABSTRACT
 RESEARCH DESIGN AND METHODS
 RESULTS
 DISCUSSION
 REFERENCES
 
In humans, overt type 2 diabetes is usually preceded by decades of IR. In the male ZDF rat, this prediabetic state lasts only several weeks before they become overt diabetic at the age of ~10 wk. At the age of 8 wk, the obese ZDF rats showed markedly reduced insulin sensitivity (GIR, clamp Rd) compared with their lean littermates. According to the prevailing view that starvation induces IR (33), we measured insulin sensitivity by the glucose clamp technique after 24 and 72 h of starvation in both rat groups. Consistent with the constant levels of FFA, IMCL, and LCACoA in muscle of obese rats after a fast of 24 and 72 h, there was no change in insulin-induced muscle Rd detectable after prolonged starvation. After 72 h of starvation, lean rats demonstrated lower FFA, IMCL, and LCACoA compared with the values after 24 h of starvation, which might reflect a different state of intermediary lipid metabolism after nearly complete mobilization of fat stores, as mentioned below. In fact, muscle Rd during basal conditions (i.e., basal EGP) was increased after 72 h of starvation, which was consistent with the reduced serum and tissue lipid parameters. However, whole body insulin sensitivity (GIR) was reduced in lean rats after prolonged starvation, which was based on a nonsuppressable EGP by insulin, reflecting hepatic IR after 72 h of starvation.

The biochemical characterization of the different muscle fiber types used for this study confirmed the classification of wTA, EDL, and soleus muscle as "fast twitch, glycolytic," "intermediary," and "slow twitch, oxidative," respectively (Table 1). Specifically, the reduction of maximal HK activity in all three muscles of the obese rats was consistent with their degree of IR (Table 2). As expected, mitochondrial fatty acid oxidation capacity (HOAD activity) was low in glycolytic and high in oxidative muscles. Additionally, HOAD activity was reduced (P < 0.05) in wTA but not in EDL or soleus of the obese strain. For Sprague-Dawley rats, histochemically determined muscle fiber compositions of 76 muscles have been reported and demonstrated that 89% of total skeletal muscle mass was comprised of glycolytic fiber types (71% for type IIB and 18% for type IID/X fibers) and only 11% oxidative fiber types (6% for type I and 5% for type IIA fibers; see Ref. 11). Assuming a similar proportion of fiber type composition of total skeletal mass in ZDF rats, the importance of glycolytic muscles for insulin sensitivity in rats is evident (28).

Fed state.

The higher IMCL values of the obese rats were consistent with their degree of IR. The relative IMCL interstrain differences were most pronounced in wTA (394%) followed by EDL and soleus (333 and 304%, respectively) and predicted the relative responses of IMCL resulting from starvation described later. In spite of these important differences, the levels of plasma FFA, as well as the total LCACoA levels, were identical in both strains. The markedly increased serum triglyceride levels during fed conditions seem to determine IMCL values rather than FFA. Additionally, the obese rats exhibited higher body weight, which has been shown to be a result of a reduced lean-to-fat mass ratio (13). All of these factors have been shown to correlate with higher IMCL values and IR in rats (24) and in humans. Malonyl-CoA levels in soleus were not significantly different between the two strains as opposed to previous reports (50, 51). It seems questionable whether the small, although statistically significant, differences of malonyl-CoA levels detected in wTA and EDL were sufficient to influence beta-oxidation.

Transition to starvation and to refeeding.

In lean rats starved for 72 h, starvation-induced elevated levels of FFA, ketone bodies, and IMCL as well as total LCACoAs decreased. These decreases were consistent with a nearly complete mobilization of fat stores in lean animals after 72 h of food deprivation in contrast to obese rats. Therefore, the results for the lean rats from this time point should be interpreted separately, since this long-lasting food deprivation might reflect a different state of starvation with a subsequent different impact on intermediary metabolism compared with that of obese rats.

Some of our recently reported findings on lipid metabolism during starvation in normal, insulin-sensitive Wistar rats (39) were confirmed by the present study: muscles with different fiber types coped with starvation-induced elevated FFA levels differently (glycolytic wTA and intermediary EDL by increasing FFA reesterification and storage as IMCL and oxidative soleus probably by beta-oxidation).

In wTA, the scarce lipid oxidative capacity available (Table 1) was strongly or even maximally activated by low malonyl-CoA levels at 48 h (Fig. 2A) in lean animals, whereas in the obese rats the decrease in malonyl-CoA levels was less pronounced. In this group of animals, the drop in malonyl-CoA was obviously insufficient for an adequate carnitine palmitoyltransferase (CPT) I function and subsequent efficient fatty acid oxidation, and FFA had to be stored as IMCL (Fig. 3A). In line with this interpretation were the EDL figures. In the obese, there was no significant change in malonyl-CoA and a rise for IMCL up to a level of 6 arbitrary units (AU; Fig. 3B), and in the lean there was a significant reduction of malonyl-CoA by 0.6 nmol/g together with an IMCL increase up to a level of <3 AU. In the oxidative soleus, however, neither malonyl-CoA nor IMCL values experienced any change at any time. In glycolytic muscle, cytosolic malonyl-CoA levels depend primarily on the production of acetyl-CoA via glycolysis, whose activity will be strongly diminished during starvation. The concomitant increase in IMCL and fall of malonyl-CoA values support the concept that, as a reaction to increased FFA availability during starvation, glycolytic muscle (wTA and EDL) will activate lipid oxidation more the lower its maximal oxidative capacity and then store the rest as IMCL. The smaller malonyl-CoA changes observed in the muscles of obese rats probably reflected their reduced HK activity and their inherent IR. Referring to data from the literature, the concentrations of malonyl-CoA measured in our study (wTA ~600 nM, EDL ~400 nM) should inhibit CPT I at all times (37, 59). But we cannot assume, however, that the concentration required for 50% inhibition (IC50) determined in isolated mitochondria [34 nM according to McGarry et al. (37)] necessarily is the IC50 of the intact muscle. To solve this question McGarry and Brown (36) suggested the possible distribution of total muscle malonyl-CoA to subcellular compartments unavailable to the CPT I enzyme. Yet, the muscle fatty acyl-CoA concentration might also be high enough during starvation (reflected by increased LCACoA levels in starved animals) to displace a significant fraction of malonyl-CoA from the enzyme (60). In liver, the sensitivity of CPT I to malonyl-CoA inhibition has been reported to decrease in fasted rats (44). This may also be true for CPT I in rat muscle.

In line with this interpretation, malonyl-CoA concentrations rose on refeeding in glycolytic wTA and EDL of the lean group. Because IMCL declined already at 72 h in the lean rat muscles because of their exhausted fat stores, no additional drop in IMCL was detected when refeeding the animals. Chien et al. (8) reported rapid increases in malonyl-CoA levels in Sprague-Dawley rats on refeeding for their gastrocnemius (60% within 1 h), presumably white gastrocnemius, and their soleus muscle (100% within 1 h). However, the initial fed-state value of ~2 nmol/g was not obtained before 12 h of refeeding. These findings agree with our data. We observed increases in malonyl-CoA in wTA and EDL of lean insulin-sensitive rats after refeeding them overnight. The soleus muscle, however, showed no such dynamics during fed-to-starved-to-refed transition.

Because we did not observe any starvation-induced changes in the malonyl-CoA content of the soleus muscle, we conclude that, in contrast to glycolytic muscles, the oxidative soleus in both strains did obviously not require an activated beta-oxidation via reduced malonyl-CoA levels nor an enhanced IMCL storage to cope with the starvation-induced increased FFA supply. Actually, according to all biochemical and physiological parameters measured, soleus was only affected a little by the feeding status or the insulin-resistant condition. The question arises whether, during starvation, malonyl-CoA plays the same role in oxidative as in glycolytic muscle. In soleus with its low glycolytic capacity, malonyl-CoA could partly be derived from mitochondrial lipid oxidation and export of citrate. This supports the additional existence of a malonyl-CoA-independent mechanism for transfer of LCACoAs to mitochondria, which has recently been described (23, 25). Furthermore, a higher concentration of LCACoA-binding protein (ACBP) has been reported for soleus vs. EDL muscle and for obese vs. lean Zucker rats (14). In our study, the levels of total LCACoA increased from wTA over EDL to soleus. The increase in ACBP could be an attempt to protect the cell against too high concentrations of LCACoA in the cytosol while maintaining the availability of fatty acids as energy substrate in the oxidative muscle.

The decrement in malonyl-CoA in the glycolytic muscles was larger in the lean animals compared with the insulin-resistant obese, hinting at a higher metabolic flexibility in the former. The obese animals, although having much higher IMCL levels, appeared to be metabolically "inflexible" due to a relatively smaller decrement in malonyl-CoA, whose levels were obviously not permissive for appropriate CPT I function and subsequent adequate fatty acid oxidation. Besides the diminished capacity for lipid oxidation, total lipid (FFA plus triglyceride) concentration in plasma is elevated in the obese rats. Therefore, obese rats have to store lipids as IMCL for two reasons. First, the smaller decrement of malonyl-CoA that prevents appropriate lipid oxidation and, second, the greater amount of lipids entering the muscle cell. Therefore, our observations support the regulatory fuel-sensing role of malonyl-CoA to control fatty acid oxidation in glycolytic muscles in the fed-to-starved and in the starved-to-refed transition in lean insulin-sensitive rats, whereas in the obese insulin-resistant animals this fuel-sensing system is obviously defective, reflecting an impaired metabolic flexibility (35, 43, 48).

On absolute terms, the starvation-induced changes in IMCL were far larger in the obese animals (for wTA and EDL, respectively, 3.2 and 1.2 AU in lean vs. 6.2 and 2.3 AU in obese rats within 24 h of starvation). These changes occurred in parallel to those observed for plasma FFA levels (Figs. 1 and 3), confirming the influence of FFA on the dynamics of IMCL (7). In both rat strains, plasma FFA levels were identical in the fed state and up to 48 h of starvation despite highly different IMCL values. These findings suggest larger esterification rates fueled by increased fluxes of FFA in the obese rats, finally leading to accumulation of IMCL. The higher FFA levels in obese rats measured during the glucose clamp study might be related to the long-term pentobarbital sodium anesthesia in contrast to the short-term isoflurane anesthesia for blood collections in all other studies.

During starvation, skeletal muscle lipoprotein lipase (LPL) activity is increased compared with adipose tissue LPL, leading to an increased uptake of triglyceride-derived fatty acids in the skeletal muscle cell (30). Because the obese animals display higher serum triglyceride levels compared with lean animals, an increased uptake of triglyceride-derived fatty acids might be an additional cause for the elevated absolute IMCL values in obese compared with lean animals during starvation.

LCACoA.

The dissociation of changes in LCACoA and IMCL levels in the presence of starvation-induced elevated FFA supports the concept that intramyocellular reesterification of fatty acids is a physiological mechanism to control LCACoA levels and thereby efficiently prevents impairment of insulin signaling, at least in glycolytic muscles. That triglyceride accumulation protects against fatty acid-induced lipotoxicity in the context of apoptosis has also been reported from in vitro studies with cells (31).

The lower insulin sensitivity (GIR, Rd) in insulin-resistant obese ZDF rats compared with their lean littermates occurred in the presence of comparable levels of total LCACoAs in all three muscle types. Elevated LCACoA levels in muscle have been identified in rats and mice being fed a high-fat diet and demonstrating IR (12, 22, 40). The elevated saturated and monounsaturated LCACoAs (SAT + MUFA) in obese rats compared with lean rats might be consistent with the notion of the metabolically more deleterious effects of SAT + MUFA compared with PUFA (10, 55).

It is concluded that IMCL is the most robust noninvasive biomarker for IR in ZDF rats compared with any other metabolic tissue or blood parameter determined in this study; however, muscle type-specific differences regarding enzymatic capacity and thus fatty acid metabolism have to be considered when applying this biomarker. Our study supports the concept of "metabolic inflexibility" in the obese ZDF rats, which is reflected by markedly increased IMCL levels and a smaller drop in malonyl-CoA levels during starvation in wTA and EDL than in the lean littermates. The concomitant increase in IMCL with the fall of malonyl-CoA supports the concept that, as a reaction to starvation-induced FFA availability, muscle will activate lipid oxidation more the lower its oxidative capacity (wTA > EDL > soleus) and then store the rest as IMCL.


    FOOTNOTES
 

Address for reprint requests and other correspondence: A. W. Herling, Therapeutic Dept. Metabolism, Pharmacology, H 821, Sanofi-Aventis Deutschland GmbH, Industriepark Hoechst, 65926 Frankfurt/Main, Germany (e-mail: andreas.herling{at}sanofi-aventis.com)

The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.


    REFERENCES
 TOP
 ABSTRACT
 RESEARCH DESIGN AND METHODS
 RESULTS
 DISCUSSION
 REFERENCES
 

  1. Anderwald C, Bernroider E, Krssak M, Stingl H, Brehm A, Bischof MG, Nowotny P, Roden M, and Waldhausl W. Effects of insulin treatment in type 2 diabetic patients on intracellular lipid content in liver and skeletal muscle. Diabetes 51: 3025–3032, 2002.[Abstract/Free Full Text]
  2. Bachmann OP, Dahl DB, Brechtel K, Machann J, Haap M, Maier T, Loviscach M, Stumvoll M, Claussen CD, Schick F, Haring HU, and Jacob S. Effects of intravenous and dietary lipid challenge on intramyocellular lipid content and the relation with insulin sensitivity in humans. Diabetes 50: 2579–2584, 2001.[Abstract/Free Full Text]
  3. Bergmeyer HU. Methoden der Enzymatischen Analyse. Weinheim, Germany: Verlag Chemie, 1983.
  4. Boden G, Lebed B, Schatz M, Homko C, and Lemieux S. Effects of acute changes of plasma free fatty acids on intramyocellular fat content and insulin resistance in healthy subjects. Diabetes 50: 1612–1617, 2001.[Abstract/Free Full Text]
  5. Boden G and Shulman GI. Free fatty acids in obesity and type 2 diabetes: defining their role in the development of insulin resistance and beta-cell dysfunction. Eur J Clin Invest 32, Suppl 3: 14–23, 2002.
  6. Boesch C, Slotboom J, Hoppeler H, and Kreis R. In vivo determination of intra-myocellular lipids in human muscle by means of localized 1H-MR-spectroscopy. Magn Reson Med 37: 484–493, 1997.[Web of Science][Medline]
  7. Brechtel K, Dahl DB, Machann J, Bachmann OP, Wenzel I, Maier T, Claussen CD, Haring HU, Jacob S, and Schick F. Fast elevation of the intramyocellular lipid content in the presence of circulating free fatty acids and hyperinsulinemia: a dynamic 1H-MRS study. Magn Reson Med 45: 179–183, 2001.[CrossRef][Web of Science][Medline]
  8. Chien D, Dean D, Saha AK, Flatt JP, and Ruderman NB. Malonyl-CoA content and fatty acid oxidation in rat muscle and liver in vivo. Am J Physiol Endocrinol Metab 279: E259–E265, 2000.[Abstract/Free Full Text]
  9. Cooney GJ, Thompson AL, Furler SM, Ye J, and Kraegen EW. Muscle long-chain acyl CoA esters and insulin resistance. Ann NY Acad Sci 967: 196–207, 2002.[Web of Science][Medline]
  10. Cortright RN, Muoio DM, and Dohm GL. Skeletal muscle lipid metabolism: a frontier for new insights into fuel homeostasis. Nutr Biochem 8: 228–245, 1997.[CrossRef]
  11. Delp MD and Duan C. Composition and size of type I, IIA, IID/X, and IIB fibers and citrate synthase activity of rat muscle. J Appl Physiol 80: 261–270, 1996.[Abstract/Free Full Text]
  12. Ellis BA, Poynten A, Lowy AJ, Furler SM, Chisholm DJ, Kraegen EW, and Cooney GJ. Long-chain acyl-CoA esters as indicators of lipid metabolism and insulin sensitivity in rat and human muscle. Am J Physiol Endocrinol Metab 279: E554–E560, 2000.[Abstract/Free Full Text]
  13. Even PC, Rolland V, Roseau S, Bouthegourd JC, and Tome D. Prediction of basal metabolism from organ size in the rat: relationship to strain, feeding, age, and obesity. Am J Physiol Regul Integr Comp Physiol 280: R1887–R1896, 2001.[Abstract/Free Full Text]
  14. Franch J, Knudsen J, Ellis BA, Pedersen PK, Cooney GJ, and Jensen J. Acyl-CoA binding protein expression is fiber type- specific and elevated in muscles from the obese insulin-resistant Zucker rat. Diabetes 51: 449–454, 2002.[Abstract/Free Full Text]
  15. Freidenberg GR, Reichart D, Olefsky JM, and Henry RR. Reversibility of defective adipocyte insulin receptor kinase activity in non-insulin-dependent diabetes mellitus. Effect of weight loss. J Clin Invest 82: 1398–1406, 1988.[Web of Science][Medline]
  16. Goodpaster BH, He J, Watkins S, and Kelley DE. Skeletal muscle lipid content and insulin resistance: evidence for a paradox in endurance-trained athletes. J Clin Endocrinol Metab 86: 5755–5761, 2001.[Abstract/Free Full Text]
  17. Houmard JA, Tanner CJ, Yu C, Cunningham PG, Pories WJ, MacDonald KG, and Shulman GI. Effect of weight loss on insulin sensitivity and intramuscular long-chain fatty acyl-CoAs in morbidly obese subjects. Diabetes 51: 2959–2963, 2002.[Abstract/Free Full Text]
  18. Hulver MW, Berggren JR, Cortright RN, Dudek RW, Thompson RP, Pories WJ, MacDonald KG, Cline GW, Shulman GI, Dohm GL, and Houmard JA. Skeletal muscle lipid metabolism with obesity. Am J Physiol Endocrinol Metab 284: E741–E747, 2003.[Abstract/Free Full Text]
  19. Itani SI, Ruderman NB, Schmieder F, and Boden G. Lipid-induced insulin resistance in human muscle is associated with changes in diacylglycerol, protein kinase C, and IkappaB-alpha. Diabetes 51: 2005–2011, 2002.[Abstract/Free Full Text]
  20. Jacob S, Machann J, Rett K, Brechtel K, Volk A, Renn W, Maerker E, Matthaei S, Schick F, Claussen CD, and Haring HU. Association of increased intramyocellular lipid content with insulin resistance in lean nondiabetic offspring of type 2 diabetic subjects. Diabetes 48: 1113–1119, 1999.[Abstract]
  21. Jucker BM, Schaeffer TR, Haimbach RE, Mayer ME, Ohlstein DH, Smith SA, Cobitz AR, and Sarkar SK. Reduction of intramyocellular lipid following short-term rosiglitazone treatment in Zucker fatty rats: an in vivo nuclear magnetic resonance study. Metabolism 52: 218–225, 2003.[CrossRef][Web of Science][Medline]
  22. Kim JK, Gimeno RE, Higashimori T, Kim HJ, Choi H, Punreddy S, Mozell RL, Tan G, Stricker-Krongrad A, Hirsch DJ, Fillmore JJ, Liu ZX, Dong J, Cline G, Stahl A, Lodish HF, and Shulman GI. Inactivation of fatty acid transport protein 1 prevents fat-induced insulin resistance in skeletal muscle. J Clin Invest 113: 756–763, 2004.[CrossRef][Web of Science][Medline]
  23. Kim JY, Koves TR, Yu GS, Gulick T, Cortright RN, Dohm GL, and Muoio DM. Evidence of a malonyl-CoA-insensitive carnitine palmitoyltransferase I activity in red skeletal muscle. Am J Physiol Endocrinol Metab 282: E1014–E1022, 2002.[Abstract/Free Full Text]
  24. Korach-Andre M, Gao J, Gounarides JS, Deacon R, Islam A, and Laurent D. Relationship between visceral adiposity and intramyocellular lipid content in two rat models of insulin resistance. Am J Physiol Endocrinol Metab 288: E106–E116, 2005.[Abstract/Free Full Text]
  25. Koves TR, Noland RC, Bates AL, Henes ST, Muoio DM, and Cortright RN. Subsarcolemmal and intermyofibrillar mitochondria play distinct roles in regulating skeletal muscle fatty acid metabolism. Am J Physiol Cell Physiol 288: C1074–C1082, 2005.[Abstract/Free Full Text]
  26. Krssak M, Falk Petersen K, Dresner A, DiPietro L, Vogel SM, Rothman DL, Roden M, and Shulman GI. Intramyocellular lipid concentrations are correlated with insulin sensitivity in humans: a 1H NMR spectroscopy study. Diabetologia 42: 113–116, 1999.[CrossRef][Web of Science][Medline]
  27. Kuhlmann J, Neumann-Haefelin C, Belz U, Kalisch J, Juretschke HP, Stein M, Kleinschmidt E, Kramer W, and Herling AW. Intramyocellular lipid and insulin resistance: a longitudinal in vivo 1H-spectroscopic study in Zucker diabetic fatty rats. Diabetes 52: 138–144, 2003.[Abstract/Free Full Text]
  28. Kuhlmann J, Neumann-Haefelin C, Belz U, Kramer W, Juretschke HP, and Herling AW. Correlation between insulin resistance and intramyocellular lipid levels in rats. Magn Reson Med 53: 1275–1282, 2005.[CrossRef][Web of Science][Medline]
  29. Levin K, Daa Schroeder H, Alford FP, and Beck-Nielsen H. Morphometric documentation of abnormal intramyocellular fat storage and reduced glycogen in obese patients with type II diabetes. Diabetologia 44: 824–833, 2001.[CrossRef][Web of Science][Medline]
  30. Lewis GF, Carpentier A, Adeli K, and Giacca A. Disordered fat storage and mobilization in the pathogenesis of insulin resistance and type 2 diabetes. Endocr Rev 23: 201–229, 2002.[Abstract/Free Full Text]
  31. Listenberger LL, Han X, Lewis SE, Cases S, Farese RV Jr, Ory DS, and Schaffer JE. Triglyceride accumulation protects against fatty acid-induced lipotoxicity. Proc Natl Acad Sci USA 100: 3077–3082, 2003.[Abstract/Free Full Text]
  32. Machann J, Haring H, Schick F, and Stumvoll M. Intramyocellular lipids and insulin resistance. Diabetes Obes Metab 6: 239–248, 2004.[CrossRef][Web of Science][Medline]
  33. Mansell PI and Macdonald IA. The effect of starvation on insulin-induced glucose disposal and thermogenesis in humans. Metabolism 39: 502–510, 1990.[CrossRef][Web of Science][Medline]
  34. Marceau P, Biron S, Hould FS, Marceau S, Simard S, Thung SN, and Kral JG. Liver pathology and the metabolic syndrome X in severe obesity. J Clin Endocrinol Metab 84: 1513–1517, 1999.[Abstract/Free Full Text]
  35. McGarry JD. Banting lecture 2001: dysregulation of fatty acid metabolism in the etiology of type 2 diabetes. Diabetes 51: 7–18, 2002.[Free Full Text]
  36. McGarry JD and Brown NF. The mitochondrial carnitine palmitoyltransferase system. From concept to molecular analysis. Eur J Biochem 244: 1–14, 1997.[Web of Science][Medline]
  37. McGarry JD, Mills SE, Long CS, and Foster DW. Observations on the affinity for carnitine, and malonyl-CoA sensitivity, of carnitine palmitoyltransferase I in animal and human tissues. Demonstration of the presence of malonyl-CoA in non-hepatic tissues of the rat. Biochem J 214: 21–28, 1983.[Web of Science][Medline]
  38. Montell E, Turini M, Marotta M, Roberts M, Noe V, Ciudad CJ, Mace K, and Gomez-Foix AM. DAG accumulation from saturated fatty acids desensitizes insulin stimulation of glucose uptake in muscle cells. Am J Physiol Endocrinol Metab 280: E229–E237, 2001.[Abstract/Free Full Text]
  39. Neumann-Haefelin C, Beha A, Kuhlmann J, Belz U, Gerl M, Quint M, Biemer-Daub G, Broenstrup M, Stein M, Kleinschmidt E, Schaefer HL, Schmoll D, Kramer W, Juretschke HP, and Herling AW. Muscle-type specific intramyocellular and hepatic lipid metabolism during starvation in wistar rats. Diabetes 53: 528–534, 2004.[Abstract/Free Full Text]
  40. Oakes ND, Cooney GJ, Camilleri S, Chisholm DJ, and Kraegen EW. Mechanisms of liver and muscle insulin resistance induced by chronic high-fat feeding. Diabetes 46: 1768–1774, 1997.[Abstract]
  41. Perseghin G, Scifo P, De Cobelli F, Pagliato E, Battezzati A, Arcelloni C, Vanzulli A, Testolin G, Pozza G, Del Maschio A, and Luzi L. Intramyocellular triglyceride content is a determinant of in vivo insulin resistance in humans: a 1H-13C nuclear magnetic resonance spectroscopy assessment in offspring of type 2 diabetic parents. Diabetes 48: 1600–1606, 1999.[Abstract]
  42. Randle PJ, Garland PB, Newsholme EA, and Hales CN. The glucose fatty acid cycle in obesity and maturity onset diabetes mellitus. Ann NY Acad Sci 131: 324–333, 1965.[Web of Science][Medline]
  43. Rasmussen BB, Holmback UC, Volpi E, Morio-Liondore B, Paddon-Jones D, and Wolfe RR. Malonyl coenzyme A and the regulation of functional carnitine palmitoyltransferase-1 activity and fat oxidation in human skeletal muscle. J Clin Invest 110: 1687–1693, 2002.[CrossRef][Web of Science][Medline]
  44. Robinson IN and Zammit VA. Sensitivity of carnitine acyltransferase I to malonly-CoA inhibition in isolated rat liver mitochondria is quantitatively related to hepatic malonyl-CoA concentration in vivo. Biochem J 206: 177–179, 1982.[Web of Science][Medline]
  45. Roden M. How free fatty acids inhibit glucose utilization in human skeletal muscle. News Physiol Sci 19: 92–96, 2004.[Abstract/Free Full Text]
  46. Roden M, Krssak M, Stingl H, Gruber S, Hofer A, Furnsinn C, Moser E, and Waldhausl W. Rapid impairment of skeletal muscle glucose transport/phosphorylation by free fatty acids in humans. Diabetes 48: 358–364, 1999.[Abstract]
  47. Roden M, Price TB, Perseghin G, Petersen KF, Rothman DL, Cline GW, and Shulman GI. Mechanism of free fatty acid-induced insulin resistance in humans. J Clin Invest 97: 2859–2865, 1996.[Web of Science][Medline]
  48. Ruderman NB, Saha AK, Vavvas D, and Witters LA. Malonyl-CoA, fuel sensing, and insulin resistance. Am J Physiol Endocrinol Metab 276: E1–E18, 1999.[Abstract/Free Full Text]
  49. Ryysy L, Hakkinen AM, Goto T, Vehkavaara S, Westerbacka J, Halavaara J, and Yki-Jarvinen H. Hepatic fat content and insulin action on free fatty acids and glucose metabolism rather than insulin absorption are associated with insulin requirements during insulin therapy in type 2 diabetic patients. Diabetes 49: 749–758, 2000.[Abstract]
  50. Saha AK, Kurowski TG, Colca JR, and Ruderman NB. Lipid abnormalities in tissues of the KKAy mouse: effects of pioglitazone on malonyl-CoA and diacylglycerol. Am J Physiol Endocrinol Metab 267: E95–E101, 1994.[Abstract/Free Full Text]
  51. Saha AK, Kurowski TG, and Ruderman NB. A malonyl-CoA fuel-sensing mechanism in muscle: effects of insulin, glucose, and denervation. Am J Physiol Endocrinol Metab 269: E283–E289, 1995.[Abstract/Free Full Text]
  52. Schick F, Eismann B, Jung WI, Bongers H, Bunse M, and Lutz O. Comparison of localized proton NMR signals of skeletal muscle and fat tissue in vivo: two lipid compartments in muscle tissue. Magn Reson Med 29: 158–167, 1993.[Web of Science][Medline]
  53. Shulman GI. Cellular mechanisms of insulin resistance. J Clin Invest 106: 171–176, 2000.[Web of Science][Medline]
  54. Shulman GI, Rothman DL, Jue T, Stein P, DeFronzo RA, and Shulman RG. Quantitation of muscle glycogen synthesis in normal subjects and subjects with non-insulin-dependent diabetes by 13C nuclear magnetic resonance spectroscopy. N Engl J Med 322: 223–228, 1990.[Abstract]
  55. Stein DT, Stevenson BE, Chester MW, Basit M, Daniels MB, Turley SD, and McGarry JD. The insulinotropic potency of fatty acids is influenced profoundly by their chain length and degree of saturation. J Clin Invest 100: 398–403, 1997.[Web of Science][Medline]
  56. Szczepaniak LS, Babcock EE, Schick F, Dobbins RL, Garg A, Burns DK, McGarry JD, and Stein DT. Measurement of intracellular triglyceride stores by 1H spectroscopy: validation in vivo. Am J Physiol Endocrinol Metab 276: E977–E989, 1999.[Abstract/Free Full Text]
  57. Virkamaki A, Korsheninnikova E, Seppala-Lindroos A, Vehkavaara S, Goto T, Halavaara J, Hakkinen AM, and Yki-Jarvinen H. Intramyocellular lipid is associated with resistance to in vivo insulin actions on glucose uptake, antilipolysis, and early insulin signaling pathways in human skeletal muscle. Diabetes 50: 2337–2343, 2001.[Abstract/Free Full Text]
  58. Wietek BM, Machann J, Mader I, Thamer C, Haring HU, Claussen CD, Stumvoll M, and Schick F. Muscle type dependent increase in intramyocellular lipids during prolonged fasting of human subjects: a proton MRS study. Horm Metab Res 36: 639–644, 2004.[CrossRef][Web of Science][Medline]
  59. Winder WW, Arogyasami J, Barton RJ, Elayan IM, and Vehrs PR. Muscle malonyl-CoA decreases during exercise. J Appl Physiol 67: 2230–2233, 1989.[Abstract/Free Full Text]
  60. Winder WW, Arogyasami J, Elayan IM, and Cartmill D. Time course of exercise-induced decline in malonyl-CoA in different muscle types. Am J Physiol Endocrinol Metab 259: E266–E271, 1990.[Abstract/Free Full Text]
  61. Yu C, Chen Y, Cline GW, Zhang D, Zong H, Wang Y, Bergeron R, Kim JK, Cushman SW, Cooney GJ, Atcheson B, White MF, Kraegen EW, and Shulman GI. Mechanism by which fatty acids inhibit insulin activation of insulin receptor substrate-1 (IRS-1)-associated phosphatidylinositol 3-kinase activity in muscle. J Biol Chem 277: 50230–50236, 2002.[Abstract/Free Full Text]



This article has been cited by other articles:


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
J. F. Ndisang, N. Lane, and A. Jadhav
Upregulation of the heme oxygenase system ameliorates postprandial and fasting hyperglycemia in type 2 diabetes
Am J Physiol Endocrinol Metab, May 1, 2009; 296(5): E1029 - E1041.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
J. F. Ndisang and A. Jadhav
Heme oxygenase system enhances insulin sensitivity and glucose metabolism in streptozotocin-induced diabetes
Am J Physiol Endocrinol Metab, April 1, 2009; 296(4): E829 - E841.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
C. M. Schummer, U. Werner, N. Tennagels, D. Schmoll, G. Haschke, H.-P. Juretschke, M. S. Patel, M. Gerl, W. Kramer, and A. W. Herling
Dysregulated pyruvate dehydrogenase complex in Zucker diabetic fatty rats
Am J Physiol Endocrinol Metab, January 1, 2008; 294(1): E88 - E96.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
290/5/E989    most recent
00459.2005v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (5)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Beha, A.
Right arrow Articles by Herling, A. W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Beha, A.
Right arrow Articles by Herling, A. W.


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online
Copyright © 2006 by the American Physiological Society.